Arcutis Biotherapeutics Inc
Top 10 Superinvestors by Shares Owned
This chart shows the top 10 superinvestors based on the number of shares they owned in 2026-Q1 and 2026-Q2. According to the most recent SEC 13F filing, 6 superinvestors own shares of Arcutis Biotherapeutics Inc (ARQT), although recent data may remain incomplete due to pending filings.
Quarter-over-Quarter Change (%)
This chart highlights the quarter-over-quarter change (%) in the number of superinvestors holding Arcutis Biotherapeutics Inc (ARQT), the total shares they held, and the total reported dollar value. It gives a clear view of whether there is ongoing momentum. The dotted lines at the top and bottom adjust longer bars to keep smaller data points visible for better comparison.
Superinvestors' Activity (%) Over the Last 4 Quarters
This chart shows superinvestors' activity with Arcutis Biotherapeutics Inc (ARQT) over the last four quarters, highlighting the percentage of investors who added, increased, decreased, held, or exited their positions, revealing shifts in sentiment over time.
Superinvestors' Past Actions
This chart displays superinvestors' past actions with Arcutis Biotherapeutics Inc (ARQT) over the last 10 years (40 quarters), helping to visualize the collective momentum and investment trends over time.
Superinvestors ownership
| Superinvestor | Portfolio % | Reported Value | Recent Activity |
|---|---|---|---|
Amy C Hui@Y-intercept (hong Kong) Ltd
| 0.04% | $1.981M 75,572 shares@ 26.23 avg price | New Position |
Mikael Aho@Handelsbanken Fonder Ab
| 0.01% | $1.148M 43,800 shares@ 26.22 avg price | Increased 6.06% |
Santhosh Palani@Psp Research Llc
| 0.28% | $516,534 19,700 shares@ 26.22 avg price | |
Lorraine Fang@Gamma Investing Llc
| 0.01% | $26,587 1,014 shares@ 26.22 avg price | Decreased -7.39% |
Michelle Johnston@1620 Investment Advisors, Inc.
| 0.02% | $18,642 711 shares@ 26.22 avg price | Decreased -18.74% |
Brandon Yee@Versant Capital Management, Inc
| 0.01% | $2,098 80 shares@ 26.23 avg price |
1-6 of 6